5.46 - 5.64
4.95 - 8.28
2.0K / 2.4K (Avg.)
-282.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.14%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-11.95%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-4.15%
Negative EBIT growth while VALMT.HE is at 11.76%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-4.15%
Negative operating income growth while VALMT.HE is at 11.76%. Joel Greenblatt would press for urgent turnaround measures.
-2.59%
Negative net income growth while VALMT.HE stands at 17.19%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-4.35%
Negative EPS growth while VALMT.HE is at 16.28%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-4.35%
Negative diluted EPS growth while VALMT.HE is at 16.28%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.70%
Share count expansion well above VALMT.HE's 0.43%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.84%
Diluted share count expanding well above VALMT.HE's 0.78%. Michael Burry would fear significant dilution to existing owners' stakes.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-55.90%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-66.85%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-29.30%
Negative 10Y revenue/share CAGR while VALMT.HE stands at 46.98%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
22.74%
5Y revenue/share CAGR at 50-75% of VALMT.HE's 39.66%. Martin Whitman would worry about a lagging mid-term growth trajectory.
9.81%
3Y revenue/share CAGR under 50% of VALMT.HE's 20.88%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
177.06%
10Y OCF/share CAGR under 50% of VALMT.HE's 733.20%. Michael Burry would worry about a persistent underperformance in cash creation.
-7.70%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
10.84%
Positive 3Y OCF/share CAGR while VALMT.HE is negative. John Neff might see a big short-term edge in operational efficiency.
302.27%
Net income/share CAGR 1.25-1.5x VALMT.HE's 212.43%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
344.99%
5Y net income/share CAGR above 1.5x VALMT.HE's 195.15%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
39.06%
Below 50% of VALMT.HE's 111.92%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
50.41%
Equity/share CAGR of 50.41% while VALMT.HE is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
71.58%
5Y equity/share CAGR above 1.5x VALMT.HE's 45.43%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
30.65%
3Y equity/share CAGR at 75-90% of VALMT.HE's 37.35%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.69%
Firm’s AR is declining while VALMT.HE shows 2.94%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
0.61%
Inventory shrinking or stable vs. VALMT.HE's 4.64%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
3.38%
Asset growth above 1.5x VALMT.HE's 1.93%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
5.29%
75-90% of VALMT.HE's 5.93%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
-0.20%
We’re deleveraging while VALMT.HE stands at 0.21%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
3.59%
We expand SG&A while VALMT.HE cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.